Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2024

Open Access 07-05-2024 | Hypopituitarism | Case Report

Partial hypopituitarism with ACTH deficiency as the main manifestation as a complication of hemorrhagic fever with renal syndrome

Authors: Shaomin Shi, Aoni Zhang, Jingjing Zhang, Shaoyong Xu

Published in: BMC Endocrine Disorders | Issue 1/2024

Login to get access

Abstract

Hypopituitarism is a relatively rare complication of hemorrhagic fever with renal syndrome. However, almost all available reported cases were total anterior pituitary hypofunction, isolated growth-hormone deficiency, or isolated gonadotropin deficiency. Here, we firstly describe a patient with partial hypopituitarism with ACTH deficiency as the main manifestation as a complication of hemorrhagic fever with renal syndrome.
Literature
1.
Sehgal A, Mehta S, Sahay K, et al. Hemorrhagic fever with renal syndrome in Asia: history, pathogenesis, diagnosis, treatment, and prevention. Viruses. 2023;15(2):561.CrossRefPubMedPubMedCentral
2.
Suh DC, Park JS, Park SK, Lee HK, Chang KH. Pituitary hemorrhage as a complication of hantaviral disease. AJNR American journal of neuroradiology. 1995;16:175–8. discussion 9-80.PubMedPubMedCentral
3.
Pekic S, Cvijovic G, Stojanovic M, Kendereski A, Micic D, Popovic V. Hypopituitarism as a late complication of hemorrhagic fever. Endocrine. 2005;26:79–82.CrossRefPubMed
4.
Zivaljević V, Adanja B, Obradović M. Lukac V [Epidemiologic characteristics of hemorrhagic fever with renal syndrome in Serbia 1979–1992]. Vojnosanit Pregl. 1995;52:142–5.PubMed
5.
Hukic M, Kurt A, Torstensson S, Lundkvist A, Wiger D, Niklasson B. Haemorrhagic fever with renal syndrome in north-east Bosnia. Lancet (London, England). 1996;347:56–7.CrossRefPubMed
6.
Cirić S, Denić V, Mitrović V, Mitrović-Perisić N, Denić N. Cirić S [Manifestations of hemorrhagic fever with renal syndrome in a military unit stationed in a combat zone]. Vojnosanit Pregl. 2003;60:605–11.CrossRefPubMed
7.
Forslund T, Saltevo J, Anttinen J, et al. Complications of nephropathia epidemica: three cases. J Intern Med. 1992;232:87–90.CrossRefPubMed
8.
Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:3888–921.CrossRefPubMed
9.
Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:364–89.CrossRefPubMed
10.
Yedinak C, Hameed N, Gassner M, Brzana J, McCartney S, Fleseriu M. Recovery rate of adrenal function after surgery in patients with acromegaly is higher than in those with non-functioning pituitary tumors: a large single center study. Pituitary. 2015;18:701–9.CrossRefPubMed
11.
Bleicken B, Hahner S, Loeffler M, et al. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Clin Endocrinol. 2010;72:297–304.CrossRef
12.
Settergren B, Boman J, Linderholm M, Wiström J, Hägg E, Arvidsson PA. A case of nephropathia epidemica associated with panhypopituitarism and nephrotic syndrome. Nephron. 1992;61:234–5.CrossRefPubMed
13.
Hautala T, Sironen T, Vapalahti O, et al. Hypophyseal hemorrhage and panhypopituitarism during Puumala Virus Infection: Magnetic Resonance Imaging and detection of viral antigen in the hypophysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2002;35:96–101.CrossRefPubMed
14.
15.
Hullinghorst RL, Steer A. Pathology of epidemic hemorrhagic fever. Ann Intern Med. 1953;38:77–101.CrossRefPubMed
16.
Lukes RJ. The pathology of thirty-nine fatal cases of epidemic hemorrhagic fever. Am J Med. 1954;16:639–50.CrossRefPubMed
17.
Terajima M, Hayasaka D, Maeda K, Ennis FA. Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers? Immunol Lett. 2007;113:117–20.CrossRefPubMedPubMedCentral
18.
Tarvainen M, Mäkelä S, Mustonen J, Jaatinen P. Autoimmune polyendocrinopathy and hypophysitis after Puumala hantavirus infection. Endocrinol Diabetes Metab Case Rep. 2016;2016:16–0084.PubMedPubMedCentral
19.
Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E. Hypopituitarism. Lancet (London, England). 2007;369:1461–70.CrossRefPubMed
20.
Stojanovic M, Pekic S, Cvijovic G, et al. High risk of hypopituitarism in patients who recovered from hemorrhagic fever with renal syndrome. J Clin Endocrinol Metab. 2008;93:2722–8.CrossRefPubMed
21.
22.
Cironi KA, Decater T, Iwanaga J, Dumont AS, Tubbs RS. Arterial Supply to the Pituitary Gland: A Comprehensive Review. World neurosurgery. 2020;142:206–11.CrossRefPubMed
23.
Ahn HJ, Chung JH, Kim DM, Yoon NR, Kim CM. Hemorrhagic fever with renal syndrome accompanied by panhypopituitarism and central diabetes insipidus: a case report. J Neurovirol. 2018;24:382–7.CrossRefPubMed
24.
Kim NH, Cho JG, Ahn YK, et al. A case of torsade de pointes associated with hypopituitarism due to hemorrhagic fever with renal syndrome. J Korean Med Sci. 2001;16:355–9.CrossRefPubMedPubMedCentral
25.
Sarıgüzel N, Hofmann J, Canpolat AT, et al. Dobrava hantavirus infection complicated by panhypopituitarism, Istanbul, Turkey, 2010. Emerg Infect Dis. 2012;18:1180–3.CrossRefPubMedPubMedCentral
26.
Lee HW, van der Groen G. Hemorrhagic fever with renal syndrome. Prog Med Virol. 1989;36:62–102.PubMed
Metadata
Title
Partial hypopituitarism with ACTH deficiency as the main manifestation as a complication of hemorrhagic fever with renal syndrome
Authors
Shaomin Shi
Aoni Zhang
Jingjing Zhang
Shaoyong Xu
Publication date
07-05-2024
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2024
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-024-01587-4

Other articles of this Issue 1/2024

BMC Endocrine Disorders 1/2024 Go to the issue

Research

Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma

Research

Preserved seasonal variation in glycemic control in patients with type 2 diabetes mellitus during COVID-19: a 3-year-long retrospective cohort study in older adults in Japan

Study Protocol

Summary of clinical investigation plan for The DIATEC trial: in-hospital diabetes management by a diabetes team and continuous glucose monitoring or point of care glucose testing – a randomised controlled trial

Research

Prospective study to evaluate radioactive iodine of 20 mCi vs 10–15 mCi in Graves’ disease

Research

Effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Research

The associations of risk of cardiovascular disease with development stages of diabetes in Chinese population: findings from a retrospective cohort study in QuZhou city
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits